Preliminary Q2 Revenue Surges 129% to $2M on Acquisitions
HYEX sits 73% above its 52-week low of $0.805 on light trading volume (0.1× avg).
Summary
Preliminary Q2 revenue tops $2 million, a 129% year-over-year jump driven by the Gummy USA merger and Imaraïs Beauty acquisition. The Imaraïs deal launched with a nearly 4-million-gummy initial order shipped to over 4,000 stores, signaling rapid distribution scale. Management sees a path to $20 million in annualized revenue by year-end, a sharp ramp from the $2 million quarterly run rate. This follows the $4.55 million Imaraïs acquisition announced in May and the Q1 73% revenue growth, showing the roll-up strategy is gaining traction. The preliminary nature of the figures adds some uncertainty, but the magnitude of the beat and the large initial order are concrete positives.
At the time of this announcement, HYEX was trading at $1.39 on OTC in the Life Sciences sector, with a market capitalization of approximately $20.5M. The 52-week trading range was $0.81 to $4.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.